BIOMAT Database Logo BIOMAT Database Logo

Intrathecal baclofen therapy for stiff-man syndrome and progressive encephalomyelopathy with rigidity and myoclonus. 1997

C Stayer, and V Tronnier, and J Dressnandt, and E Mauch, and G Marquardt, and K Rieke, and G Müller-Schwefe, and F Schumm, and H M Meinck
Department of Neurology, University of Heidelberg, Germany.

We report on eight patients with stiff-man syndrome (SMS) or its "plus" variant, progressive encephalomyelopathy with rigidity and myoclonus (PERM) receiving intrathecal baclofen via pump. In six of the patients, follow-ups continued for approximately 2.5 to 6.5 years after pump implantation. Intrathecal baclofen was an effective last-resort alternative for patients who responded poorly to or did not tolerate oral antispasticity medications. General mobility increased, and spasms and rigidity were reduced; however, no complete remissions were observed either before or after pump implantation. PERM patients showed more severe and rapid progression of symptoms and more attacks of autonomic dysregulation than SMS patients. They also required higher doses and more rapid dosage increases. Complications of intrathecal baclofen therapy included spasm-induced rupture of the catheter, catheter dislocation causing radicular symptoms, and pump malfunction resulting in inaccurate dosage administration. Patients suffered fewer side effects with intrathecal baclofen than with oral medication, but overdose resulted in a transient, comalike state in one patient and sudden dosage reduction due to pump failure was fatal in another.

UI MeSH Term Description Entries
D007278 Injections, Spinal Introduction of therapeutic agents into the spinal region using a needle and syringe. Injections, Intraspinal,Injections, Intrathecal,Intraspinal Injections,Intrathecal Injections,Spinal Injections,Injection, Intraspinal,Injection, Intrathecal,Injection, Spinal,Intraspinal Injection,Intrathecal Injection,Spinal Injection
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009125 Muscle Relaxants, Central A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358) Centrally Acting Muscle Relaxants,Central Muscle Relaxants,Relaxants, Central Muscle
D009127 Muscle Rigidity Continuous involuntary sustained muscle contraction which is often a manifestation of BASAL GANGLIA DISEASES. When an affected muscle is passively stretched, the degree of resistance remains constant regardless of the rate at which the muscle is stretched. This feature helps to distinguish rigidity from MUSCLE SPASTICITY. (From Adams et al., Principles of Neurology, 6th ed, p73) Cogwheel Rigidity,Extrapyramidal Rigidity,Gegenhalten,Nuchal Rigidity,Rigidity, Muscular,Catatonic Rigidity,Extensor Rigidity,Cogwheel Rigidities,Gegenhaltens,Muscular Rigidity,Rigidities, Cogwheel,Rigidity, Catatonic,Rigidity, Cogwheel,Rigidity, Extensor,Rigidity, Extrapyramidal,Rigidity, Muscle,Rigidity, Nuchal
D009207 Myoclonus Involuntary shock-like contractions, irregular in rhythm and amplitude, followed by relaxation, of a muscle or a group of muscles. This condition may be a feature of some CENTRAL NERVOUS SYSTEM DISEASES; (e.g., EPILEPSY, MYOCLONIC). Nocturnal myoclonus is the principal feature of the NOCTURNAL MYOCLONUS SYNDROME. (From Adams et al., Principles of Neurology, 6th ed, pp102-3). Myoclonus, Action,Myoclonus, Nocturnal,Myoclonus, Palatal,Polymyoclonus,Myoclonic Jerk,Myoclonic Jerking,Myoclonus Simplex,Myoclonus, Eyelid,Myoclonus, Intention,Myoclonus, Lower Extremity,Myoclonus, Oculopalatal,Myoclonus, Segmental,Myoclonus, Sleep,Myoclonus, Upper Extremity,Action Myoclonus,Extremity Myoclonus, Lower,Extremity Myoclonus, Upper,Eyelid Myoclonus,Intention Myoclonus,Jerk, Myoclonic,Jerking, Myoclonic,Jerks, Myoclonic,Lower Extremity Myoclonus,Myoclonic Jerks,Nocturnal Myoclonus,Oculopalatal Myoclonus,Palatal Myoclonus,Segmental Myoclonus,Simplex, Myoclonus,Sleep Myoclonus,Upper Extremity Myoclonus
D002493 Central Nervous System Diseases Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord. CNS Disease,Central Nervous System Disease,Central Nervous System Disorder,CNS Diseases,Central Nervous System Disorders
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

C Stayer, and V Tronnier, and J Dressnandt, and E Mauch, and G Marquardt, and K Rieke, and G Müller-Schwefe, and F Schumm, and H M Meinck
Stiff-man syndrome treated with intrathecal baclofen.
November 1993, Neurology,
C Stayer, and V Tronnier, and J Dressnandt, and E Mauch, and G Marquardt, and K Rieke, and G Müller-Schwefe, and F Schumm, and H M Meinck
A patient with reflex myoclonus and muscle rigidity: "jerking stiff-man syndrome".
December 1980, Journal of neurology, neurosurgery, and psychiatry,
C Stayer, and V Tronnier, and J Dressnandt, and E Mauch, and G Marquardt, and K Rieke, and G Müller-Schwefe, and F Schumm, and H M Meinck
Intrathecal baclofen therapy in stiff-man syndrome: a double-blind, placebo-controlled trial.
October 1995, Neurology,
C Stayer, and V Tronnier, and J Dressnandt, and E Mauch, and G Marquardt, and K Rieke, and G Müller-Schwefe, and F Schumm, and H M Meinck
Trialing of intrathecal baclofen therapy for refractory stiff-person syndrome.
January 2013, Regional anesthesia and pain medicine,
C Stayer, and V Tronnier, and J Dressnandt, and E Mauch, and G Marquardt, and K Rieke, and G Müller-Schwefe, and F Schumm, and H M Meinck
Intrathecal baclofen treatment for stiff-man syndrome: pump failure may be fatal.
November 1994, Neurology,
C Stayer, and V Tronnier, and J Dressnandt, and E Mauch, and G Marquardt, and K Rieke, and G Müller-Schwefe, and F Schumm, and H M Meinck
Case Series: Intrathecal Baclofen Therapy in Stiff-Person Syndrome.
October 2018, Neuromodulation : journal of the International Neuromodulation Society,
C Stayer, and V Tronnier, and J Dressnandt, and E Mauch, and G Marquardt, and K Rieke, and G Müller-Schwefe, and F Schumm, and H M Meinck
[Progressive encephalomyelitis with rigidity and myoclonus : Stiff tongue as initial symptom].
February 2018, Der Nervenarzt,
C Stayer, and V Tronnier, and J Dressnandt, and E Mauch, and G Marquardt, and K Rieke, and G Müller-Schwefe, and F Schumm, and H M Meinck
Successful intrathecal baclofen therapy for seronegative stiff-person syndrome: a case report.
September 2008, Acta neurologica Taiwanica,
C Stayer, and V Tronnier, and J Dressnandt, and E Mauch, and G Marquardt, and K Rieke, and G Müller-Schwefe, and F Schumm, and H M Meinck
Review of 23 patients affected by the stiff man syndrome: clinical subdivision into stiff trunk (man) syndrome, stiff limb syndrome, and progressive encephalomyelitis with rigidity.
November 1998, Journal of neurology, neurosurgery, and psychiatry,
C Stayer, and V Tronnier, and J Dressnandt, and E Mauch, and G Marquardt, and K Rieke, and G Müller-Schwefe, and F Schumm, and H M Meinck
Successful Treatment of Stiff Person Syndrome with Intrathecal Baclofen.
January 2019, Journal of rehabilitation medicine. Clinical communications,
Copied contents to your clipboard!